BSE Live
Nov 11, 13:45Prev. Close
6692.20
Open Price
6669.25
Bid Price (Qty.)
6498.45 (4)
Offer Price (Qty.)
6502.00 (170)
NSE Live
Nov 11, 13:45Prev. Close
6691.50
Open Price
6711.00
Bid Price (Qty.)
6501.50 (2)
Offer Price (Qty.)
6503.00 (16)
| Key Financial Ratios of Divis Laboratories (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 82.53 | 60.27 | 68.69 | 111.52 | 74.75 | |
| Diluted EPS (Rs.) | 82.53 | 60.27 | 68.69 | 111.52 | 74.75 | |
| Cash EPS (Rs.) | 97.85 | 74.64 | 81.62 | 123.26 | 84.38 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 564.87 | 512.11 | 480.96 | 441.82 | 350.15 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 564.87 | 512.11 | 480.96 | 441.82 | 350.15 | |
| Revenue from Operations/Share (Rs.) | 353.21 | 296.04 | 292.62 | 337.53 | 262.55 | |
| PBDIT/Share (Rs.) | 125.28 | 96.00 | 102.18 | 150.53 | 110.10 | |
| PBIT/Share (Rs.) | 110.11 | 81.74 | 89.26 | 138.79 | 100.47 | |
| PBT/Share (Rs.) | 110.04 | 81.62 | 89.23 | 138.76 | 100.43 | |
| Net Profit/Share (Rs.) | 82.68 | 60.38 | 68.69 | 111.53 | 74.75 | |
| NP After MI And SOA / Share (Rs.) | 82.68 | 60.38 | 68.69 | 111.53 | 74.75 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 35.47 | 32.42 | 34.92 | 44.59 | 41.93 | |
| PBIT Margin (%) | 31.17 | 27.60 | 30.50 | 41.12 | 38.26 | |
| PBT Margin (%) | 31.15 | 27.57 | 30.49 | 41.11 | 38.25 | |
| Net Profit Margin (%) | 23.40 | 20.39 | 23.47 | 33.04 | 28.47 | |
| NP After MI And SOA Margin (%) | 23.40 | 20.39 | 23.47 | 33.04 | 28.47 | |
| Return on Networth/Equity (%) | 14.63 | 11.78 | 14.28 | 25.24 | 21.34 | |
| Return on Capital Employed (%) | 18.85 | 15.26 | 17.76 | 30.25 | 27.60 | |
| Return on Assets (%) | 12.93 | 10.34 | 12.62 | 22.13 | 18.41 | |
| Total Debt/Equity (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Asset Turnover Ratio (%) | 0.58 | 0.52 | 0.56 | 0.74 | 64.68 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 6.94 | 7.57 | 8.46 | 6.99 | 5.55 | |
| Quick Ratio (X) | 4.71 | 5.08 | 5.73 | 4.62 | 3.62 | |
| Inventory Turnover Ratio (X) | 2.92 | 1.05 | 1.03 | 1.44 | 3.25 | |
| Dividend Payout Ratio (NP) (%) | 36.33 | 49.75 | 43.67 | 17.93 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 30.69 | 40.24 | 36.75 | 16.22 | 0.00 | |
| Earnings Retention Ratio (%) | 63.67 | 50.25 | 56.33 | 82.07 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 69.31 | 59.76 | 63.25 | 83.78 | 0.00 | |
| Coverage Ratios | ||||||
| Interest Coverage Ratios (%) | 1,660.00 | 848.00 | 4,048.48 | 4,994.76 | 3,065.41 | |
| Interest Coverage Ratios (Post Tax) (%) | 1,660.00 | 848.00 | 4,048.48 | 4,994.76 | 3,065.41 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 149,274.15 | 87,093.88 | 70,796.44 | 114,081.32 | 94,204.00 | |
| EV/Net Operating Revenue (X) | 15.95 | 11.10 | 9.11 | 12.73 | 13.52 | |
| EV/EBITDA (X) | 44.96 | 34.24 | 26.10 | 28.55 | 32.23 | |
| MarketCap/Net Operating Revenue (X) | 16.34 | 11.61 | 9.66 | 13.05 | 13.83 | |
| Retention Ratios (%) | 63.66 | 50.25 | 56.32 | 82.06 | 0.00 | |
| Price/BV (X) | 10.22 | 6.71 | 5.88 | 9.97 | 10.37 | |
| Price/Net Operating Revenue | 16.34 | 11.61 | 9.66 | 13.05 | 13.83 | |
| Earnings Yield | 0.01 | 0.02 | 0.02 | 0.03 | 0.02 |
11.11.2025
Accumulate Divis Laboratories; target of Rs 7050: Prabhudas Lilladher
10.11.2025
Sell Divis Laboratories; target of Rs 5400: ICICI Securities
10.09.2025
Reduce Divis Laboratories; target of Rs 5400: Geojit Financial Services
07.08.2025
Accumulate Divis Laboratories; target of Rs 6550: Prabhudas Lilladher
24.05.2024
Divi's Labs Q4 preview: Revenue, net profit to grow on normalised base, better product mix
04.11.2023
Divi's Labs Q2 Preview: Earnings likely to improve sequentially on better margins, product mix
14.08.2023
Divi's Labs Q1 Preview: Base effect to pressure earnings, brokerages predict sequential recovery
19.05.2023
Divi's Labs Preview: Unfavourable base, elevated input costs to turn Q4 a sour pill